Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2009 | 09-2009 | 06-2009 | 03-2009 | 12-2008 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -8,441 | -6,842 | -5,115 | -3,169 | -14,596 |
| Depreciation Amortization | 187 | 146 | 102 | 52 | 165 |
| Other Working Capital | 614 | 237 | 398 | 654 | 86 |
| Other Operating Activity | 697 | 456 | 258 | 153 | 1,299 |
| Operating Cash Flow | $-6,944 | $-6,003 | $-4,358 | $-2,310 | $-13,046 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 2,714 | 2,714 | 2,571 | 2,501 | 10,571 |
| PPE Investments | 116 | 0 | -2 | N/A | -124 |
| Investing Cash Flow | $2,830 | $2,714 | $2,570 | $2,501 | $10,448 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | N/A | N/A | N/A | 9 |
| Other Financing Activity | 2,910 | 2,940 | 1,245 | 0 | 0 |
| Financing Cash Flow | $2,910 | $2,940 | $1,245 | $N/A | $9 |
| Beginning Cash Position | 1,431 | 1,431 | 1,431 | 1,431 | 4,021 |
| End Cash Position | 227 | 1,081 | 888 | 1,622 | 1,431 |
| Net Cash Flow | $-1,204 | $-349 | $-543 | $191 | $-2,590 |
| Free Cash Flow | |||||
| Operating Cash Flow | -6,944 | -6,003 | -4,358 | -2,310 | -13,046 |
| Capital Expenditure | -2 | -2 | -2 | N/A | -124 |
| Free Cash Flow | -6,946 | -6,005 | -4,359 | -2,310 | -13,170 |